Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bicalutamide Implants (Biolen) With Radiation Therapy in Patients With Localized Prostate Cancer

NCT04943536 is registered in ClinicalTrials.gov with Alessa Therapeutics Inc. as lead sponsor.

NCT NCT04943536
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04943536 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bicalutamide Implants (Biolen) With Radiation Therapy in Patients With Localized Prostate Cancer
Lead sponsor
Alessa Therapeutics Inc.
Phase
Phase 1
Overall status
Active, not recruiting
Start date
December 7, 2021
Completion date
August 15, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate adenocarcinoma